Innovative and accredited continuing medical education for today’s practicing clinicians.

CME Institute is trusted by physicians across medical specialties for premium continuing education that yields the highest educational outcomes. These ACCME-accredited activities make the latest research, novel therapies, and clinical best practices accessible and approachable for physician, NP, PA, and PharmD learners.

  • Expert-led insights to improve patient outcomes
  • Multi-modal courses to suit all learning styles
  • Timely topics for relevant application to practice
  • Razor-focused approach to innovation that includes documentary-style video and micro-learning Tweetorials
  • A commitment to collective mindfulness 

Bipolar Disorder Education Collection by CME Institute

Recent courses

  • Self-study / Enduring
  • Bipolar Disorder
  • Depression
  • Child and Adolescent Psychiatry
  • Diagnostic Tools
  • Psychopharmacology
  • Side Effects
What are the evidence-based pharmacologic treatment approaches for pediatric patients with bipolar depression?
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Self-study / Enduring
  • Alzheimer Disease
  • Dementia
  • Diagnostic Tools
Experts offer an overview of best practices for managing early-stage Alzheimer disease as well as a look at the future.
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Journal
  • Mood Disorders
  • Bipolar Disorder
Do you tend to use combination pharmacotherapy regimens in patients with bipolar disorder? Will patients receiving 3 or more drugs have better outcomes?
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Journal
  • Bipolar Disorder
  • Posttraumatic Stress Disorder
  • Schizophrenia/ Schizoaffective Disorders
For patients who have PTSD and also have a severe mental illness, can psychotherapies for PTSD still be effective? If so, what component might offer greater efficacy?
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Self-study / Enduring
  • Alzheimer Disease
  • Neurology
How do investigational drugs for Alzheimer disease differ from those currently prescribed to patients? Dr Burke shares her insights.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Self-study / Enduring
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • Patient/Physician Communication
In this webcast about early-stage Alzheimer disease, Drs Burke and Apostolova highlight important conversations to have with patients and their care partners on topics such as diet, exercise, driving, and plans for the later stage of illness.
5
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Self-study / Enduring
  • Alzheimer Disease
  • Dementia
  • Diagnostic Tools
Great strides in research on Alzheimer disease diagnostic biomarkers and treatment targets have taken place over the past 2 decades. Listen as Dr Goldfarb highlights exciting developments.
0
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Self-study / Enduring
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
What are the steps for diagnosing Alzheimer disease? Are you familiar with diagnostic criteria and assessment tools? In this webcast, walk through the process with an expert.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Self-study / Enduring
  • Adherence
  • Antipsychotics
  • Delivery of Care
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
What are some of the challenges you face in overcoming adherence issues and providing patient-centered care for people living with schizophrenia? Drs Harvey and Kane offer evidence and clinical experience on these topics in this journal CME activity.
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Self-study / Enduring
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Journal
  • Cross-Cultural Psychiatry
  • Delivery of Care
  • Substance Use Disorders
Explore the neurobiological, psychological, psychosocial, and cultural determinants of opioid use disorder, and review approaches to integrated, culturally competent care.
0
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Journal
  • Anxiety
  • Obsessive-Compulsive and Related Disorders
  • Women’s Mental Health
When screening for perinatal OCD, do you ask infant-specific questions? If not, patients may not make the connection to their symptoms. Learn more in this journal CME article.
0
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation

Pages

My Courses

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.